Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00225680 · ClinicalTrials.gov registry record · NA
In Stent ELUTES Study
A NA study, sponsored by Cook Group Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 124
- Enrollment target
NCT00225680 is a NA study that has completed, run by Cook Group Incorporated. The registered enrollment target is 124 participants.
The verdict
NCT00225680, a NA study, has completed, sponsored by Cook Group Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
Study Summary
This trial will compare the long term safety and effectiveness of the V Flex Plus PTX Drug Eluting coronary stent with conventional treatment for in-stent restenosis for coronary arteries.
Interventions
- DEVICE drug eluting coronary stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2002-04 |
| Est. Completion | 2005-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00225680
The ClinicalTrials.gov registry entry for NCT00225680 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Group Incorporated, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which drug eluting coronary stent is the first listed.
NCT00225680 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00225680 about?
NCT00225680 is a clinical study titled "In Stent ELUTES Study". This trial will compare the long term safety and effectiveness of the V Flex Plus PTX Drug Eluting coronary stent with conventional treatment for in-stent restenosis for coronary arteries.
What is the current status of trial NCT00225680?
This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2002-04. Estimated completion is 2005-08.
What interventions are being tested in trial NCT00225680?
The interventions under investigation include: drug eluting coronary stent (DEVICE).
Who is sponsoring clinical trial NCT00225680?
This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.